Ophthotech Stock Price (NASDAQ:OPHT)

Add to My Stocks
$4.36 $0.14 (3.11%) OPHT stock closing price Feb 21, 2017 (Closing)
21 FEB 2017
amigobulls logo
OPHT hand_up
OPHT vs S&P 500
Closing Price: Feb 21, 2017
$4.36 ( -3.11%)
S&P 500
2365.4 ( 0.6%)
52 Week Price Range
1 Year Return: -90.77%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Ophthotech Snapshot Video

27 5 2

OPHT Stock Details

Prev Close* : $4.50
Market Cap:
Day Low: $4.35
52 Week Low: $4.27
Open: $4.54
Volume: 971422
Day High: $4.56
52 Week High: $65.96

Latest Stock Market News

Latest Articles

Ophthotech News - From Partners

3 Great Stocks to Beat the Biotech Blues   by Zacks on Dec 13, 2016

OPHT Stockcharts

View OPHT PE ratio, PS ratio stocks charts and compare with peers.
OPHT Chart
Note: Compare Ophthotech stock price history with the index and industry peers.

Ophthotech Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Ophthotech Financial Ratios

Asset Turnover
Receivables Turnover

OPHT Industry Peers

Company Price Change (%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Uniquire (QURE)6.10.21 (3.33%)
Regeneron Pharma (REGN)371.610.43 (0.12%)
Tracon Pharma (TCON)3.850.1 (2.53%)
Novartis (NVS)77.040.16 (0.21%)
Adverum (ADVM)2.80 (0%)
Alimera Sciences (ALIM)1.250.03 (2.46%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)22.412.5 (12.56%)
Fate Therapeutics (FATE)4.380.45 (11.45%)
Nymox Pharmaceutical (NYMX)3.540.12 (3.51%)
Myriad Genetics (MYGN)19.080.46 (2.47%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Evogene (EVGN)5.4210.11 (2.07%)
OncoMed Pharma (OMED)8.910.18 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Trevena (TRVN)4.272.86 (40.11%)
Momenta Pharma (MNTA)16.052.95 (15.53%)
Peregrine Pharma (PPHM)0.4790.07 (12.73%)
Cytokinetics (CYTK)10.40.85 (7.56%)
Argos Therapeutics (ARGS)4.40.3 (6.38%)
Sorrento Therapeutics (SRNE)5.250.3 (5.41%)
Immunomedics (IMMU)5.060.28 (5.24%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017

Ophthotech Financial Statements

income statement20152014201320122011
Net Sales Or Revenues51.5M41.25M---
Net Income-105.71M-98.18M-51.14M-14.56M-18.63M
Total Operating Expense175.03M121.76M47.42M13.67M19.62M
view Ophthotech Corp income statement
balance sheet20152014201320122011
Total Assets428.85M498.37M217.68M4.87M7.72M
Total Liabilities368.9M351.24M47.96M128.34M110.21M
Shareholders Equity59.94M147.12M169.72M-123.47M-102.48M
view Ophthotech Corp balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities21.01M218.09M-3.01M0.33M-1.25M
Net Cash From (Used By) Operating Activities-78.53M111.08M-48.77M-13.1M-19.12M
Increase (Decrease) In Prop Plant And Equipment-2.6M-1.65M-0.01M--
view Ophthotech Corp cashflow statement

Ophthotech Corp Stock News - Partner Headlines

Ophthotech Stock Message Board

Ophthotech stock lost -3.02 %, and the last close price as of 17 Feb, 2017 is 4.5 for OPHT stock. The total market value as denoted by 160.64M for Ophthotech, is the market value of the company's outstanding shares. Ophthotech valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Ophthotech stock price and Ophthotech share price mean the same thing. The volume of shares traded stood at 877098 on the last trading day, as is evident from Ophthotech stock chart, and OPHT stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Ophthotech does not pay dividends. To check the historical stock price movement, all time high, and all time low of OPHT, view Ophthotech stock price history.